Delivery Order SPE2DB20D1109-SPE2DB22FQ06X
- Not listed
- This federal contract award is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $6,686.19 and an ultimate completion date of April 29, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran...
- This federal contract award is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The $1,474.54 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on July 25, 2022, with a completion date of July 26, 2022. The contract is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 3 mg/0.5 ml pens. The contract has a ceiling value of $5,309.38 and an ultimate completion date of September 14, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award is for the delivery of pharmaceutical products, specifically Trulicity 0.75 mg/0.5 ml pen 0.5 ml, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has a ceiling value of $19,093.77 and a period of performance through May 2, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract has a ceiling value of $3,540.10 and runs through June 27, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen (0.5 ml) with a ceiling value of $5,736.72. The contract has a delivery order structure and firm fixed pricing, and no set-aside designation was used. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The $1,451.40 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of May 24, 2023 and is a firm fixed price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $3,338.07 and a period of performance through March 22, 2022. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
- This federal contract award is for the delivery of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5ml to the Defense Logistics Agency (DLA). The contract, valued at $11,411.35, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FQ06XDelivery Order
This federal contract award is for the delivery of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The contract, awarded to prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., has a ceiling value of $1,708.38 and runs through September 14, 2022. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business category. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical healthcare commodities to support military and veteran healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/13/22 |